Department of Surgery, College of Medicine and Life Sciences, University of Toledo, Toledo, OH.
Jobst Vascular Institute, ProMedica Physicians, Toledo, OH.
J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1021-1027. doi: 10.1016/j.jvsv.2022.02.017. Epub 2022 Mar 17.
Risk stratification using the plasma D-dimer level and Wells score has been proposed as a safe strategy to rule out acute lower extremity deep vein thrombosis (DVT) and limit the use of duplex ultrasound (DUS) for low-risk patients. A widely used diagnostic protocol defining the role of pretest probability and D-dimer testing in lieu of DUS has not been reported. Our aim was to define the risk of DVT in a standard population of emergency department patients who had presented with acute lower extremity symptoms and determine the role of DUS for these patients.
Outpatients presenting to the emergency department with symptoms concerning for lower extremity DVT were prospectively enrolled. All the patients underwent whole leg DUS and clinical and laboratory assessments for DVT using the Wells criteria and plasma D-dimer testing. The patients were stratified into three groups according to the combination of their Wells score and plasma D-dimer level. The prevalence of DVT and the statistical performance of the combined Wells score and plasma D-dimer were compared.
A total of 3087 patients were enrolled. Most of the patients had had a negative plasma D-dimer level and Wells score (n = 2290 patients). A total of 222 patients had had a positive plasma D-dimer level and Wells score. The overall prevalence of acute DVT in the present study was 7.3%. Of the 2290 patients with a negative Wells score and negative plasma D-dimer level, 4 had had a diagnosis of DVT (negative predictive value, 99.8%). In contrast, DVT was present in 181 of 222 patients (81.5%) with a positive Wells score and plasma D-dimer level (positive predictive value, 81.5%). The plasma D-dimer level also correlated with the DVT location, and the D-dimer levels were highest for the patients with proximal DVT.
The combination of a negative Wells score and negative plasma D-dimer level can safely exclude the presence of DVT. Patients with a negative Wells score and negative plasma D-dimer level are unlikely to benefit from DUS. In contrast, patients with a positive D-dimer level and positive Wells score will benefit from whole leg DUS to rule out the presence of high-risk DVT.
使用血浆 D-二聚体水平和 Wells 评分进行风险分层,已被提出作为一种安全策略,用于排除急性下肢深静脉血栓形成(DVT)并限制对低危患者进行双功超声(DUS)检查。目前尚未报道一种广泛使用的诊断方案,该方案定义了术前概率和 D-二聚体检测在替代 DUS 中的作用。我们的目的是确定在出现急性下肢症状的急诊科标准人群中 DVT 的风险,并确定这些患者进行 DUS 的作用。
前瞻性纳入因下肢 DVT 症状就诊于急诊科的门诊患者。所有患者均接受了下肢全长 DUS 检查以及 Wells 标准和血浆 D-二聚体检测的临床和实验室评估。根据 Wells 评分和血浆 D-二聚体水平的组合,将患者分为三组。比较 DVT 的患病率以及联合 Wells 评分和血浆 D-二聚体的统计学性能。
共纳入 3087 例患者。大多数患者的血浆 D-二聚体水平和 Wells 评分均为阴性(n=2290 例)。222 例患者的血浆 D-二聚体水平和 Wells 评分均为阳性。本研究中急性 DVT 的总体患病率为 7.3%。在 2290 例 Wells 评分和血浆 D-二聚体均为阴性的患者中,有 4 例诊断为 DVT(阴性预测值,99.8%)。相反,在 222 例 Wells 评分和血浆 D-二聚体均为阳性的患者中,有 181 例(阳性预测值,81.5%)存在 DVT。血浆 D-二聚体水平也与 DVT 部位相关,近端 DVT 患者的 D-二聚体水平最高。
阴性 Wells 评分和阴性血浆 D-二聚体水平可安全排除 DVT 的存在。阴性 Wells 评分和阴性血浆 D-二聚体水平的患者不太可能从 DUS 中获益。相反,D-二聚体水平和 Wells 评分均为阳性的患者将从下肢全长 DUS 中获益,以排除高危 DVT 的存在。